HALPRYN GLENN L 4
4 · Sorrento Therapeutics, Inc. · Filed Feb 7, 2012
Insider Transaction Report
Form 4
HALPRYN GLENN L
Director
Transactions
- Award
Non-qualified stock option
2012-02-06+140,000→ 140,000 totalExercise: $0.16From: 2013-01-01Exp: 2022-02-06→ Common Stock (140,000 underlying)